AN2 Therapeutics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 +NaN% -€44.27M -20.7% N/A -€42.49M -7.6% N/A
    €0.00 +NaN% -€55.84M +58.1% N/A -€45.97M +59.2% N/A
    €0.00 +NaN% -€35.33M +90.1% N/A -€28.86M +63.4% N/A
    €0.00 +NaN% -€18.58M +58.4% N/A -€17.67M +281.9% N/A
    €0.00 +NaN% -€11.73M +141.4% N/A -€4.63M +115.8% N/A
    €0.00 -€4.86M N/A -€2.14M N/A

    Notifications